Ares Real Estate Income Trust Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ares Real Estate Income Trust Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $498.84M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $417.49M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $353.17M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $299.22M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $218.35M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $186.59M | Mar 20, 2023 |
| FY2019 | Dec 31, 2019 | $44.82M | Mar 5, 2020 |
| FY2019 | Sep 30, 2019 | $44.23M | Mar 5, 2020 |
| FY2019 | Jun 30, 2019 | $44.92M | Mar 5, 2020 |
| FY2019 | Mar 31, 2019 | $50.69M | Mar 5, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($68.00M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($37.14M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | ($62.43M) | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | ($39.98M) | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $30.75M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | ($14.91M) | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $153.28M | Mar 14, 2022 |
| FY2015 | Dec 31, 2015 | $730.0K | Mar 3, 2016 |
| FY2015 | Sep 30, 2015 | ($128.0K) | Mar 3, 2016 |
| FY2015 | Jun 30, 2015 | $70.0K | Mar 3, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $331.58M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $281.26M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $234.38M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $195.27M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $148.58M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $121.87M | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $123.38M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $127.96M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $129.99M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $149.64M | Mar 6, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.64M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($169.49M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $15.96M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $62.53M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $49.39M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $41.13M | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $49.35M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $67.52M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $58.92M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $87.37M | Mar 6, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.27B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $5.73B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $4.64B | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $4.17B | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.99B | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $2.11B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.78B | Mar 5, 2021 |
| FY2020 | Dec 31, 2018 | $1.58B | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $1.61B | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $1.78B | Mar 6, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.75B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $4.32B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $3.52B | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $2.96B | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.21B | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $1.61B | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $1.23B | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.17B | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $1.12B | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $1.18B | Mar 7, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $655.45M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $745.82M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $795.30M | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $943.26M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $579.73M | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $401.65M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $468.63M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $333.72M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $405.87M | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $516.34M | Mar 7, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.06M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $19.55M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $15.05M | Mar 6, 2026 |
| FY2025 | Dec 31, 2022 | $13.34M | Mar 6, 2026 |
| FY2024 | Dec 31, 2021 | $10.61M | Mar 6, 2025 |
| FY2023 | Dec 31, 2020 | $11.27M | Mar 13, 2024 |
| FY2022 | Dec 31, 2019 | $97.77M | Mar 20, 2023 |
| FY2021 | Dec 31, 2018 | $10.01M | Mar 14, 2022 |
| FY2020 | Dec 31, 2017 | $10.48M | Mar 5, 2021 |
| FY2019 | Dec 31, 2016 | $13.86M | Mar 5, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.97B | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $2.70B | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $1.96B | Mar 6, 2025 |
| FY2023 | Dec 31, 2022 | $1.62B | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $1.36B | Mar 20, 2023 |
| FY2021 | Dec 31, 2020 | $965.31M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $846.57M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.00B | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $1.01B | Mar 6, 2019 |
| FY2017 | Dec 31, 2016 | $1.05B | Mar 7, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 6, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Mar 6, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | 150.64M | Mar 3, 2017 |
| FY2016 | Dec 31, 2015 | 164.12M | Mar 3, 2017 |
| FY2015 | Dec 31, 2014 | 178.40M | Mar 3, 2016 |
| FY2014 | Dec 31, 2013 | 176.01M | Mar 3, 2015 |
| FY2013 | Dec 31, 2012 | 178.13M | Mar 10, 2014 |
| FY2012 | Dec 31, 2011 | 182.33M | Mar 19, 2013 |
| FY2011 | Dec 31, 2010 | 182.72M | Mar 21, 2012 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $94.64M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $78.32M | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | $61.23M | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | $49.60M | Mar 6, 2025 |
| FY2023 | Dec 31, 2021 | $37.83M | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | $34.35M | Mar 20, 2023 |
| FY2021 | Dec 31, 2019 | $29.12M | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | $28.74M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $37.53M | Mar 5, 2020 |
| FY2018 | Dec 31, 2016 | $37.65M | Mar 6, 2019 |